Evidence map›Paper›PMID 31788999›Full record

ArticleJournal of gynecologic oncology2020

An optimized

Yoonjung Kim, Chi Heum Cho, Jung Sook Ha, Do Hoon Kim, Sun Young Kwon, Seoung Chul Oh, Kyung A Lee

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gynecologic oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Cost-Effectiveness Analysis of Germline and SomaticAnnals of laboratory medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yoonjung Kim *Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4370-4265
Chi Heum Cho *Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-0437-4099
Jung Sook HaDepartment of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-6475-4886
Do Hoon KimDepartment of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-9854-7850
Sun Young KwonDepartment of Pathology, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-8410-0185
Seoung Chul OhDepartment of Laboratory Medicine, Gangnam Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-8211-5466
Kyung A LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. KAL1119@yuhs.ac.ORCID https://orcid.org/0000-0001-5320-6705
Keimyung University · KRYonsei University · KRSeverance Hospital · KR

Funding

AstraZeneca Korea ESR-16-12150
6 · The paper itself

Abstract

objectiveA simultaneous detection of germline and somatic mutations in ovarian cancer (OC) using tumor materials is considered to be cost-effective for

methodsWe compared

resultsThe rate of repeated tests in a total of buffy coat, FF and FFPE was 0%, 8%, and 34%, respectively. The accuracy of

conclusionsOn the comparison of the analytical performance according to different sample types, the buffy coat was not affected by sequencing artifacts and VAF shifted variants. Therefore, the blood test should be given priority in detecting germline

Indexed as

Blood Buffy CoatBRCA1 ProteinBRCA2 ProteinFemaleGerm-Line MutationHigh-Throughput Nucleotide SequencingHumansOvarian NeoplasmsPredictive Value of TestsSpecimen HandlingBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBlood Buffy CoatBRCA1BRCA2High-Throughput Nucleotide SequencingTissue Preservation

Identifiers

PMID31788999
PMCPMC6918881
OpenAlexW2968860935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.